openPR Logo
Press release

AI for Drug Discovery Market Is Touching New Levels And Technologies in Pharmacist Industry up to 2028

12-02-2021 01:04 PM CET | Health & Medicine

Press release from: The Insight Partners

AI for Drug Discovery Market

AI for Drug Discovery Market

Drug discovery is the first step in the process of identifying a new drug and its therapeutic target. In the pharmaceutical sector, artificial intelligence (AI) is widely employed for drug discovery. Artificial intelligence technology has the ability to recognise drug targets and can help with drug design, discovery, identification, and screening of molecules in real time. Potency, bioavailability, efficacy, and toxicity are used to estimate drug discovery or new drug targets.

The Insight Partners proclaims the addition of another new report on account of the global AI for Drug Discovery market for 2021-2028. The report summaries the noticeable players in the global market with a precise end goal to give a rational position of the genuine forces of the market, while the provincial and product sections of the market are likewise anticipated in detail, keeping in mind the end goal to give a granular illustration of the market's collapse.

Get a sample Copy of this AI for Drug Discovery Market report now! @ https://www.theinsightpartners.com/sample/TIPRE00004177/?utm_source=OpenPR&utm_medium=10411

AI for Drug Discovery Market Top Leading Vendors:-
• Atomwise, Inc.
• Insilico Medicine
• BIOAGE
• IBM
• NuMedii, Inc.
• Envisagenics
• Cloud Pharmaceuticals, Inc
• BenevolentAI
• Aria Pharmaceuticals, Inc
• Gero.ai

Summing it up, the business and money related over, organization profile and ongoing development have been amalgamated into the AI for Drug Discovery Market report. The complications that are looked by every one of these organizations and business methodologies actualized by them to craft and gain high incomes in the market have equally been given.

MARKET SEGMENTATION
• Based on drug type the market is segmented as, small molecule and large molecule.
• Based on technology the market is segmented as, deep learning, machine learning.
• Based on application the market is segmented as, metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, and others.
• Based on end user the market is segmented as, pharmaceutical & biotechnological companies, academic & research institutes, and others.

What the research report offers:
-It offers a comprehensive analysis of the global AI for Drug Discovery Market
-Offers different approaches for the identification of global opportunities, threats, and risks
-It gives strategies for strategic planning
-It provides an estimation of AI for Drug Discovery Market size, shares, revenue generation, and profit margin
-It offers an in-depth analysis of the latest trends, technologies and certain methodologies for boosting the performance of the companies

The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries including Biotechnology, medical devices, pharma Industry, and many more. Trade barriers are further restraining the demand- supply outlook. As government of different regions have already announced total lockdown and temporarily shutdown of industries, the overall production process being adversely affected; thus, hinder the overall AI for Drug Discovery market globally. This report on ‘AI for Drug Discovery market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The report also showcase market trends and forecast to 2028, factoring the impact of Covid -19 Situation.

ASSESING THE COVID-19 IMPACT on AI for Drug Discovery Market? Visit Here for PDF Copy >>
https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00004177/?utm_source=OpenPR&utm_medium=10411

In This Study, The Years Considered To Estimate The Size Of AI for Drug Discovery Market Are As Follows:
History Year: 2015-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028

As the demand for new state-of-the-art solutions upsurges and more startups arise in the space which leads to growth and excessive demand for the AI for Drug Discovery - Market. This study also offers an in-depth exploration of the market with forthcoming estimates to identify current trends and investment trends for the forecast year 2021-2028. The global AI for Drug Discovery market research report implements numerous strategies and plans including the graphical and tabular representation of facts and statics, to research the Market data.

Table of Contents:
1. Introduction
2. Key Takeaways
3. Research Methodology
4. AI for Drug Discovery Market Landscape
5. AI for Drug Discovery Market – Key Market Dynamics
6. AI for Drug Discovery Market – Global Market Analysis
7. AI for Drug Discovery Market – Revenue and Forecasts to 2027 – Product Type
8. AI for Drug Discovery Market – Revenue and Forecasts to 2027 – Application
9. AI for Drug Discovery Market – Revenue and Forecasts to 2027 – Compound
10. AI for Drug Discovery Market Revenue and Forecasts to 2027 – Geographical Analysis
11. Industry Landscape
12. AI for Drug Discovery Market, Key Company Profiles
13. Appendix

Interested in Purchasing this Report? Click here @
https://www.theinsightpartners.com/buy/TIPRE00004177/?utm_source=OpenPR&utm_medium=10411

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI for Drug Discovery Market Is Touching New Levels And Technologies in Pharmacist Industry up to 2028 here

News-ID: 2482985 • Views:

More Releases from The Insight Partners

Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
3D orthopaedic scanning devices are sophisticated technology-driven systems used to scan human body components for the detection and treatment of the defect. By means of its scanning capabilities, 3D orthopaedic scanning systems help to design uniquely customised products and to find further use in surgical procedures. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017457/?utm_source=OpenPR&utm_medium=10129 Orthopedic 3D Scanners Market: Competitive Landscape and Key Developments: • Delcam Plc • Allied OSI Labs • SCANNY3D S.r.l. • AGE Solutions S.r.l. • Orthopaedic Innovation Centre • Diasu
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003656/?utm_source=OpenPR&utm_medium=10129 Prostate Cancer Diagnostics Market: Competitive Landscape and Key Developments: • MDxHealth • Telo Genomics Corp
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, O …
The Aerospace Plastics Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00005464/?utm_source=OpenPR&utm_medium=10188 Companies Profiled in this report includes: • SABIC • Victrex • Drake Plastics Ltd • Solvay • BASF SE • Evonik Industries AG • Vantage Plane Plastics • Paco Plastics & Engineering Inc. • 3P • Performance Plastics Products • Big Bear Plastics The report scrutinizes different business approaches and frameworks that
Consumer Genomics: A Guide to Understanding the Process
Consumer Genomics: A Guide to Understanding the Process
Consumer genomics market is growing as it is very frictionless. A patient can purchase a genetic test online and then receive a test kit by mail and collect a DNA sample in their own home. Patients will receive the results at home and don't need any guidance of a genetic counselor or medical practitioner. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006429/?utm_source=OpenPR&utm_medium=10129 Consumer Genomics Market: Competitive Landscape and Key Developments: •

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug